GT Biopharma Inc. (NASDAQ: GTBP) reported progress in its Phase 1 clinical trial testing GTB 3650, an experimental treatment for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE